Your Navigation:PCAR > Abstract
Search pcar
检索项:
检索词:
Abstract
Pharmaceutical Care and Research: 2019; 19(3):161-165
DOI: 10.5428/pcar20190301
Research progress in tumor-associated macrophage drug targeted delivery systems
1. WANG Xiaoyu1(1.Departmemt of Pharmacy,General Hospital of Western Theater Command,Chengdu 610036,China scncwxy@163.com)
2. GAO Shen2(2.Department of Pharmacy,Changhai Hospital,Navy Military Medical University,Shanghai 200433,China ggss99@126.com)
ABSTRACT  Tumor-associated macrophage (TAM) is abundantly distributed in tumor micro-environment,which is closely related to tumor cell growth and metastasis,immunosuppression and neovascularization.Tumor-targeted therapy strategy that focuses on TAM is a hot topic in recent years.In this paper,the factors influencing the targeted delivery of TAM by nanoparticles,the results of TAM as a living cell target for tumor tissue delivery and TAM polarity transformation were reviewed,and prospect for future development was forecasted.
Welcome to PCAR! You are the number 51 reader of this article!
Please cite this article as:
WANG Xiaoyu1,GAO Shen2,. Research progress in tumor-associated macrophage drug targeted delivery systems[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2019; 19(3): 161-165.
References:
1. Ginhoux F,Jung S.Monocytes and macrophages:developmental pathways and tissue homeostasis[J].Nat Rev Immunol,2014,14(6):392-404.
2. Lewis C E,Harney A S,Pollard J W.The multifaceted role of perivascular macrophages in tumors[J].Cancer Cell,2016,30(1):18-25.
3. Ngambenjawong C,Gustafson H H,Pun S H.Progress in tumor-associated macrophage(TAM)-targeted therapeutics[J].Adv Drug Deliv Rev,2017,114:206-221.
4. Caux C,Ramos R N,Prendergast G C,et al.A milestone review on how macrophages affect tumor growth[J].Cancer Res,2016,76(22):6439-6442.
5. Engblom C,Pfirschke C,Pittet M J.The role of myeloid cells in cancer therapies[J].Nat Rev Cancer,2016,16(7):447-462.
6. Quail D F,Joyce J A.Molecular pathways:deciphering mechanisms of resistance to macrophage-targeted therapies[J].Clin Cancer Res,2017,23(4):876-884.
7. WANG Xiaowei,LIU Xue,WANG Dan,et al.Research progress in nanodrug delivery systems for platinum-based anticancer drugs[J].Chin Med Biotechnol,2017,12(1):49-53.In Chinese.
8. Sosale N G,Spinler K R,Alvey C,et al.Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization,a species-specific ‘marker of self’ CD47,and target physical properties[J].Curr Opin Immunol,2015,35:107-112.
9. Baratta J L,Ngo A,Lopez B,et al.Cellular organization of normal mouse liver:a histological,quantitative immunocytochemical,and fine structural analysis[J].Histochem Cell Biol,2009,131(6):713-726.
10. Tanei T,Leonard F,LIU Xuewen,et al.Redirecting transport of nanoparticle albumin-bound paclitaxel to macrophages enhances therapeutic efficacy against liver metastases[J].Cancer Res,2016,76(2):429-439.
11. Chono S,Tanino T,Seki T,et al.Uptake characteristics of liposomes by rat alveolar macrophages:influence of particle size and surface mannose modification[J].J Pharm Pharmacol,2007,59(1):75-80.
12. CHANG Yanan,GUO Haili,LI Juan,et al.Adjusting the balance between effective loading and vector migration of macrophage vehicles to deliver nanoparticles[J].PLoS One,2013,8(10):e76024.
13. Yu S S,Lau C M,Thomas S N,et al.Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages[J].Int J Nanomedicine,2012,7:799-813.
14. Key J,Palange A L,Gentile F,et al.Soft discoidal polymeric nanoconstructs resist macrophage uptake and enhance vascular targeting in tumors[J].ACS Nano,2015,9(12):11628-11641.
15. MacParland S A,Tsoi K M,OUYANG Ben,et al.Phenotype determines nanoparticle uptake by human macrophages from liver and blood[J].ACS Nano,2017,11(3):2428-2443.
16. SUN Xianlei,GAO Duo,GAO Liquan,et al.Molecular imaging of tumor-infiltrating macrophages in a preclinical mouse model of breast cancer[J].Theranostics,2015,5(6):597-608.
17. LIN Yingying,WEI Chongyang,LIU Yuan,et al.Selective ablation of tumor-associated macrophages suppresses metastasis and angiogenesis[J].Cancer Sci,2013,104(9):1217-1225.
18. RUAN Shaobo,HU Chuan,TANG Xian,et al.Increased gold nanoparticle retention in brain tumors by in situ enzyme-induced aggregation[J].ACS Nano,2016,10(11):10086-10098.
19. ZHU Saijie,NIU Mengmeng,O’mary H,et al.Targeting of tumor-associated macrophages made possible by PEG-sheddable,mannose-modified nanoparticles[J].Mol Pharm,2013,10(9):3525-3530.
20. Lee S,Kivime S,Dolor A,et al.Macrophage-based cell therapies:the long and winding road[J].J Control Release,2016,28(240):527-540.
21. Choi J,Kim H Y,Ju E J,et al.Use of macrophages to deliver therapeutic and imaging contrast agents to tumors[J].Biomaterials,2012,33(16):4195-4203.
22. Miller M A,ZHENG Yaorong,Gadde S,et al.Tumor- associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(Ⅳ) pro-drug[J].Nat Commun,2015,6:8692.
23. Klyachko N L,Haney M J,ZHAO Yuling,et al.Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins[J].Nanomedicine (Lond),2014,9(9):1403-1422.
24. Sanford D E,Belt B A,Panni R Z,et al.Inflammatory monocyte mobilization decreases patient survival in pancreatic cancer:a role for targeting the CCL2/CCR2 axis[J].Clin Cancer Res,2013,19(13):3404-3415.
25. Muthana M,Kennerley A J,Hughes R,et al.Directing cell therapy to anatomic target sites in vivo with magnetic resonance targeting[J].Nat Commun,2015,6:8009.
26. DOU Huangyu,Destache C J,Morehead J R,et al.Development of a macrophage-based nanoparticle platform for antiretroviral drug delivery[J].Blood,2006,108(8):2827-2835.
27. Andón F T,Digifico E,Maeda A,et al.Targeting tumor associated macrophages:the new challenge for nanomedicine[J].Semin Immunol,2017,34:103-113.
28. Madsen S J,Baek S K,Makkouk A R,et al.Macrophages as cell-based delivery systems for nanoshells in photothermal therapy[J].Ann Biomed Eng,2012,40(2):507-515.
29. Ikehara Y,Niwa T,BIAO Le,et al.A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle[J].Cancer Res,2006,66(17):8740-8748.
30. Zanganeh S,Hutter G,Spitler R,et al.Iron oxide nanoparticles inhibit tumour growth by inducing pro-inflammatory macrophage polarization in tumour tissues[J].Nat Nanotechnol,2016,11(11):986-994.
31. Ortega R A,Barham W,Sharman K,et al.Manipulating the NF-κB pathway in macrophages using mannosylated,siRNA-delivering nanoparticles can induce immunostimulatory and tumor cytotoxic functions[J].Int J Nanomedicine,2016,11:2163-2177.
32. WANG Yi,LIN Yaoxin,QIAO Shenglin,et al.Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment[J].Biomaterials,2017,112:153-163.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330
·电子邮件:PharmCR@vip.163.com
·技术支持:中国康网
管理员入口